Director of SEC Reporting and Technical Accounting

At Braveheart Bio, we are on a mission to transform the lives of patients battling hypertrophic cardiomyopathy through cutting-edge science and our lead product candidate, BHB-1893. As we navigate the complexities of clinical-stage development, we are looking for a sharp, ambitious professional to join our Finance team as the Director of SEC Reporting and Technical Accounting. This role is a unique opportunity for an emerging finance leader to help build the financial infrastructure of a high-growth biotech company, bridging the gap between intricate technical accounting standards and the high-stakes world of SEC compliance.

In this position, you will serve as a critical architect of our financial integrity, managing complex technical accounting assessments and leading the preparation of our SEC filings. You will work directly with our leadership team to interpret the financial implications of our clinical milestones, gaining unparalleled exposure to the inner workings of a biopharmaceutical firm. If you are a detail-oriented problem solver who thrives in a fast-paced environment and wants to play a fundamental role in bringing life-changing cardiovascular therapies to patients, we invite you to help us shape the financial future of Braveheart Bio.

Requirements

• Strong understanding of accounting principles and financial reporting.
• Proficiency in MS Excel (advanced formulas, pivot tables, modeling).
• High level of accuracy and attention to detail in financial calculations.
• Ability to manage multiple deadlines in a fast-paced environment.
• Strong ethical standards and understanding of regulatory compliance.
• Degree in Finance, Accounting, or Economics; progress toward CPA/CFA is a plus.